ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.845
      0.07%
      Bitcoin
      65,055.72
      -0.13%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Atara Biotherapeutics Inc (ATRA)

      7. Atara Biotherapeutics Inc (ATRA) News

      ATRA

      Atara Biotherapeutics (ATRA)

      Atara Biotherapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ATRA
      DateTimeSourceHeadlineSymbolCompany
      08/08/20234:01PMBusiness WireAtara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational ProgressNASDAQ:ATRAAtara Biotherapeutics Inc
      08/04/20234:01PMBusiness WireAtara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
      08/01/20234:01PMBusiness WireAtara Biotherapeutics to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023NASDAQ:ATRAAtara Biotherapeutics Inc
      07/31/20234:01PMBusiness WireAtara Biotherapeutics to Participate in the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:ATRAAtara Biotherapeutics Inc
      07/07/20234:01PMBusiness WireAtara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/29/20234:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATRAAtara Biotherapeutics Inc
      06/09/20234:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/09/20234:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/09/20234:31PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/09/20234:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/07/20234:01PMBusiness WireAtara Biotherapeutics to Participate in the Goldman Sachs 44th Annual Global Healthcare ConferenceNASDAQ:ATRAAtara Biotherapeutics Inc
      06/05/20234:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/05/20239:00AMBusiness WireAtara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023NASDAQ:ATRAAtara Biotherapeutics Inc
      06/02/20237:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/02/20237:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      06/02/20234:01PMBusiness WireAtara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
      05/12/20234:33PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRAAtara Biotherapeutics Inc
      05/08/20234:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRAAtara Biotherapeutics Inc
      05/08/20234:01PMBusiness WireAtara Biotherapeutics Announces First Quarter 2023 Financial Results and Operational ProgressNASDAQ:ATRAAtara Biotherapeutics Inc
      05/05/20234:01PMBusiness WireAtara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
      05/01/20234:01PMBusiness WireAtara Biotherapeutics to Announce First Quarter 2023 Financial Results on Monday, May 8, 2023NASDAQ:ATRAAtara Biotherapeutics Inc
      04/07/20234:46PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ATRAAtara Biotherapeutics Inc
      04/07/20234:31PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ATRAAtara Biotherapeutics Inc
      03/31/20234:34PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRAAtara Biotherapeutics Inc
      03/31/20234:01PMBusiness WireAtara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATRAAtara Biotherapeutics Inc
      03/24/20234:07PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ATRAAtara Biotherapeutics Inc
      03/10/20234:22PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATRAAtara Biotherapeutics Inc
      03/06/20236:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      03/06/20236:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
      03/06/20236:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATRAAtara Biotherapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ATRA